M
The FTC wants Martin Shkreli held in contempt.
According to the regulator, the so-called “Pharma Bro” hasn’t been complying with its investigation into whether his new company, Druglike, Inc, violates his ban from working in the pharmaceutical industry. A press release calls Druglike “a Web3 drug discovery software platform,” which definitely seems like something the world needs.
FTC Asks Federal Court to Hold ‘Pharma Bro’ Martin Shkreli in Contempt
[Federal Trade Commission]
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...











